Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe plus Simvastatin vs Simvastatin in Adolescents with Heterozygous Familial Hypercholesterolemia
2004-002627-40Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in familial hypercholesterolemia (FH) comparing Simvastatin monotherapy with Ezetimibe plus Simvastatin (2 arms). Primary endpoint: Percent change in LDL-C at 6 weeks. Started Feb 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2004-002627-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002627-40.